Last reviewed · How we verify

SER120 nasal spray 750 ng/day

Serenity Pharmaceuticals, Inc. · Phase 3 active Small molecule

SER120 nasal spray 750 ng/day is a Serotonin receptor agonist Small molecule drug developed by Serenity Pharmaceuticals, Inc.. It is currently in Phase 3 development for Major depressive disorder, Generalized anxiety disorder.

SER120 is a serotonin receptor agonist.

SER120 is a serotonin receptor agonist. Used for Major depressive disorder, Generalized anxiety disorder.

At a glance

Generic nameSER120 nasal spray 750 ng/day
SponsorSerenity Pharmaceuticals, Inc.
Drug classSerotonin receptor agonist
Target5-HT1A
ModalitySmall molecule
Therapeutic areaPsychiatry
PhasePhase 3

Mechanism of action

It works by activating the 5-HT1A receptor, which is involved in regulating mood and anxiety. This leads to an increase in the levels of certain neurotransmitters, such as serotonin and dopamine, which can help alleviate symptoms of depression and anxiety.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about SER120 nasal spray 750 ng/day

What is SER120 nasal spray 750 ng/day?

SER120 nasal spray 750 ng/day is a Serotonin receptor agonist drug developed by Serenity Pharmaceuticals, Inc., indicated for Major depressive disorder, Generalized anxiety disorder.

How does SER120 nasal spray 750 ng/day work?

SER120 is a serotonin receptor agonist.

What is SER120 nasal spray 750 ng/day used for?

SER120 nasal spray 750 ng/day is indicated for Major depressive disorder, Generalized anxiety disorder.

Who makes SER120 nasal spray 750 ng/day?

SER120 nasal spray 750 ng/day is developed by Serenity Pharmaceuticals, Inc. (see full Serenity Pharmaceuticals, Inc. pipeline at /company/serenity-pharmaceuticals-inc).

What drug class is SER120 nasal spray 750 ng/day in?

SER120 nasal spray 750 ng/day belongs to the Serotonin receptor agonist class. See all Serotonin receptor agonist drugs at /class/serotonin-receptor-agonist.

What development phase is SER120 nasal spray 750 ng/day in?

SER120 nasal spray 750 ng/day is in Phase 3.

What are the side effects of SER120 nasal spray 750 ng/day?

Common side effects of SER120 nasal spray 750 ng/day include Nausea, Headache, Dizziness, Fatigue.

What does SER120 nasal spray 750 ng/day target?

SER120 nasal spray 750 ng/day targets 5-HT1A and is a Serotonin receptor agonist.

Related